Using ultrasound to evaluate white blood cell cancer in the skin

The implementation of novel imaging techniques for the evaluation of cutaneous lymphomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN14038061

Enrollment

Registered

2019-11-19

Start date

2019-12-01

Completion date

Unknown

Last updated

2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycosis fungoides (cutaneous lymphoma) Cancer Mycosis fungoides

Interventions

The study is designed to investigate the applicability of HF-USG in patients with mycosis fungoides using Vevo MD®

FUJIFILM VisualSonics, Toronto, ON, Canada ultrasound machine and to describe baseline ultrasound charateristics for mycosis fungoides and to compare these findings with standard dermoscopy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patch or plaque stage mycosis fungoides

Exclusion criteria

Exclusion criteria: 1. Clinical suspicion of mycosis fungoides lacking definitive histopathologic proof 2. Mycosis fungoides with generalized erythroderma

Design outcomes

Primary

Measure	Time frame
Ultrasound characteristics (morphology of the epidermis, dermis and subcutis) for mycosis fungoides measured using the Vevo MD® ultrasound machine at the time of investigation	—

Secondary

Measure	Time frame
Dermoscopy characteristics (pattern of the skin lesion including the morphology of vessels, follicular openings and the color of scales) for mycosis fungoides measured using skin surface microspcopy at the time of investigation	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026